В.Энхтуяа
Loading...
Товч нэр
В.Энхтуяа
Бүтэн нэр
Ванхүү Энхтуяа
Латин нэр
Vankhuu Enkhtuya
Албан тушаал
Тэнхимийн эрхлэгч
Эрдмийн цол
Дэд профессор
Харьяалал
ORCID
10 results
Now showing 1 - 10 of 10
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Evaluation of the Glucose-Lowering Effect of Bloodletting Therapy in Type 2 Diabetes Mellitus(Mongolian National University of Medical Sciences, 2024-12-12); ; ; ;Myagmardorj, RinchyenkhandObjective: This study uses a quantitative method to evaluate bloodletting therapy’s impact on lowering blood glucose levels and improving metabolic parameters in patients with type 2 diabetes mellitus (T2DM). Method: This randomized, controlled clinical trial included 110 patients diagnosed with T2DM who met the study’s inclusion criteria. Participants were randomly assigned to a control group (standard medication) and an experimental group (standard medication plus bloodletting therapy). Both groups received medicine according to the Mongolian Clinical Practice Guidelines for T2DM treatment. The experimental group additionally underwent bloodletting therapy on Day 6 of the study, following a 5-day preparation period during which they consumed 2.0 grams of a “3-seed decoction” (twice daily). The bloodletting procedure involves drawing blood from the posterior antebrachial vein (100-150 mL). The study evaluated primary outcomes, including fasting blood glucose and HbA1c levels, and secondary outcomes, such as insulin levels, C-peptide concentrations, and lipid profiles (total cholesterol, triglycerides, LDL, and HDL) at baseline, Day 30, and Day 60. Results: The experimental group demonstrated significant improvements in metabolic parameters. BMI levels decreased from 30.45±4.48 at baseline to 29.09±3.60 at Day 60 (P < 0.05), and HbA1c decreased from 9.2 ± 2.46% to 8.49 ± 1.85% (P< 0.05). Furthermore, significant reductions were observed in insulin levels (from 43.38 ± 14.12 to 25.61 ± 4.8 pmol/L; P= 0.0001) and C-peptide levels (from 4.9 to 4.2 ng/mL; P= 0.0004). The lipid profile also showed improvements, with a reduction in LDL cholesterol and triglycerides compared to the control group, although these changes were not statistically significant at Day 60. Conclusion: Integrating bloodletting therapy into the treatment regimen for T2DM provides additional benefits, including significant reductions in blood glucose, HbA1c, insulin, and C-peptide levels. Bloodletting therapy, when used in combination with standard pharmacotherapy, could offer a cost-effective and clinically beneficial treatment option for managing type 2 diabetes. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The strength and weakness of Mongolian healthcare: from nomadic Gobi to Ulaanbaatar(International Society of Global Health, 2025-03) ;Chen, Wei-Ti; ;Munkhbaatar, Khulan; Arbing, Rachel HaMongolia, the world's second-largest landlocked country, has a healthcare system shaped by Soviet and Chinese influences. While its capital, Ulaanbaatar, houses nearly half of the population with well-developed medical facilities, rural and remote areas, including the Gobi region, face significant disparities in healthcare access. Urban migration to Ulaanbaatar is driven by better economic opportunities, healthcare services, and infrastructure. Traditional Mongolian medicine (TMM) remains an integral part of healthcare, particularly in rural areas, where it is often the primary form of treatment. Despite the adoption of universal healthcare coverage, rural healthcare struggles with workforce shortages, outdated infrastructure, and limited resources. Nurses and midwives lack professional autonomy, and preventive care remains underdeveloped. To address these challenges, Mongolia can strengthen global collaborations through its 'third neighbour policy', expanding partnerships with countries like the USA and Japan to improve healthcare education and workforce capacity. Enhancing online training, telemedicine, and disease prevention programmes, particularly in rural areas, would further support healthcare development. Expanding nursing and midwifery roles, integrating health screenings into community events, and leveraging digital health technologies can bridge healthcare gaps. A holistic approach integrating modern and traditional medicine can lead to a more resilient, accessible, and culturally appropriate healthcare system.Scopus© Citations 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Nutritional composition of ghee of various animal origins produced in some silk road countries(Elsevier BV, 2024-08) ;Ulambayar, Nomin-Erdene ;Smanalieva, Jamila ;Hellwig, Anne ;Iskakova, JanylScopus© Citations 12 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Global accreditation practices for accelerated medically trained clinicians: a view of five countries(Springer Science and Business Media LLC, 2021-09) ;Antwi, James ;Arkoh, Anthony Asare ;Choge, Joseph Kiprop ;Dibo, Turi WotichaMahmud, AliasBACKGROUND: Shortages and maldistribution of healthcare workers persist despite efforts to increase the number of practitioners. Evidence to support policy planning and decisions is essential. The World Health Organization has proposed National Health Workforce Accounts (NHWA) to facilitate human resource information systems for effective health workforce planning and monitoring. In this study, we report on the accreditation practices for accelerated medically trained clinicians in five countries: Ethiopia, Ghana, Kenya, Malaysia, and Mongolia. METHOD: Using open-ended survey responses and document review, information about accreditation practices was classified using NHWA indicators. We examined practices using this framework and further examined the extent to which the indicators were appropriate for this cadre of healthcare providers. We developed a data extraction tool and noted any indicators that were difficult to interpret in the local context. RESULTS: Accreditation practices in the five countries are generally aligned with the WHO indicators with some exceptions. All countries had standards for pre-service and in-service training. It was difficult to determine the extent to which social accountability and social determinants of health were explicitly part of accreditation practices as this cadre of practitioners evolved out of community health needs. Other areas of discrepancy were interprofessional education and continuing professional development. DISCUSSION: While it is possible to use NHWA module 3 indicators there are disadvantages as well, at least for accelerated medically trained clinicians. There are aspects of accreditation practices that are not readily coded in the standard definitions used for the indicators. While the indicators provide detailed definitions, some invite social desirability bias and others are not as easily understood by practitioners whose roles continue to evolve and adapt to their health systems. CONCLUSION: Regular review and revision of indicators are essential to facilitate uptake of the NHWA for planning and monitoring healthcare providers.Scopus© Citations 9
